Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Taylor-Fishwick

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Endocrinology|September 28, 2006
Islet neogenesis associated protein transgenic mice are resistant to hyperglycemia induced by streptozotocinDavid A Taylor-Fishwick, Angela Bowman, Natasha Hamblet, et al.
Pancreas|January 2, 2007
Intramuscular injection of islet neogenesis-associated protein peptide stimulates pancreatic islet neogenesis in healthy dogsGary L Pittenger, David A Taylor-Fishwick, Robert H Johns, et al.
Journal of Diabetes Mellitus|October 17, 2015
Amelioration of type 1 diabetes following treatment of non-obese diabetic mice with INGAP and lisofyllineSarah A Tersey, Jeffery D Carter, Lawrence Rosenberg, et al.
Progress in Lipid Research|October 26, 2010
Functional and pathological roles of the 12- and 15-lipoxygenasesAnca D Dobrian, David C Lieb, Banumathi K Cole, et al.
Biochimica Et Biophysica Acta|May 22, 2003
Cloning genomic INGAP: a Reg-related family member with distinct transcriptional regulation sitesDavid A Taylor-Fishwick, Sharon Rittman, Hidayah Kendall, et al.
Molecular and Cellular Endocrinology|December 29, 2010
Targeted expression of islet neogenesis associated protein to beta cells enhances glucose tolerance and confers resistance to streptozotocin-induced hyperglycemiaTien-Jyun Chang, Jessica R Weaver, Angela Bowman, et al.
Molecular and Cellular Endocrinology|April 17, 2012
Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunctionJessica R Weaver, Theodore R Holman, Yumi Imai, et al.
Diabetologia|November 24, 2014
Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunctionDavid A Taylor-Fishwick, Jessica Weaver, Lindsey Glenn, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2017
12-Lipoxygenase Inhibitor Improves Functions of Cytokine-Treated Human Islets and Type 2 Diabetic IsletsKaiwen Ma, An Xiao, So Hyun Park, et al.
Journal of Medicinal Chemistry|July 12, 2011
Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenaseVictor Kenyon, Ganesha Rai, Ajit Jadhav, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Endocrinology|September 28, 2006
Islet neogenesis associated protein transgenic mice are resistant to hyperglycemia induced by streptozotocinDavid A Taylor-Fishwick, Angela Bowman, Natasha Hamblet, et al.
Pancreas|January 2, 2007
Intramuscular injection of islet neogenesis-associated protein peptide stimulates pancreatic islet neogenesis in healthy dogsGary L Pittenger, David A Taylor-Fishwick, Robert H Johns, et al.
Journal of Diabetes Mellitus|October 17, 2015
Amelioration of type 1 diabetes following treatment of non-obese diabetic mice with INGAP and lisofyllineSarah A Tersey, Jeffery D Carter, Lawrence Rosenberg, et al.
Progress in Lipid Research|October 26, 2010
Functional and pathological roles of the 12- and 15-lipoxygenasesAnca D Dobrian, David C Lieb, Banumathi K Cole, et al.
Biochimica Et Biophysica Acta|May 22, 2003
Cloning genomic INGAP: a Reg-related family member with distinct transcriptional regulation sitesDavid A Taylor-Fishwick, Sharon Rittman, Hidayah Kendall, et al.
Molecular and Cellular Endocrinology|December 29, 2010
Targeted expression of islet neogenesis associated protein to beta cells enhances glucose tolerance and confers resistance to streptozotocin-induced hyperglycemiaTien-Jyun Chang, Jessica R Weaver, Angela Bowman, et al.
Molecular and Cellular Endocrinology|April 17, 2012
Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunctionJessica R Weaver, Theodore R Holman, Yumi Imai, et al.
Diabetologia|November 24, 2014
Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunctionDavid A Taylor-Fishwick, Jessica Weaver, Lindsey Glenn, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2017
12-Lipoxygenase Inhibitor Improves Functions of Cytokine-Treated Human Islets and Type 2 Diabetic IsletsKaiwen Ma, An Xiao, So Hyun Park, et al.
Journal of Medicinal Chemistry|July 12, 2011
Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenaseVictor Kenyon, Ganesha Rai, Ajit Jadhav, et al.
Pageof 3